Cost burden of male infertility investigations and treatments: A survey study

Ahmed M Al-Kandari 1, Ahmad Alenezi 2

Affiliations

12 January 2020

-

doi: 10.4103/UA.UA_48_20

Purpose: Male infertility represents 50% of all infertility problems. The management of male infertility is expensive, causing a huge burden on the patients. In this study, we aimed to calculate the cost burden of male infertility investigations and treatments.

Methods: A total of 600 infertile male patients from a single center in Kuwait city were asked to fulfill an internet-based survey. The survey encompassed data about the cost of different investigations and treatments of male infertility. Patients were also asked about the preference of covering their condition either through government or by private insurance.

Results: A total of 145 patients responded to the survey. Most of the patients earned 3295 United States Dollar (USD) to 6590 USD per month. The cost of the outpatient visit ranged from 131.7 to 263.4 USD. The cost of each hormonal test was 164.5 USD while the average cost of each imaging study was 131.8-164.7 USD. Most of the patients (62.8%) received medical therapy with an expense of >988.74 USD. Varicocelectomy cost ranged from 3295 to 6590 USD while the cost of testicular sperm extraction ranged from 1644 to 3294 USD. Most patients (96.3%) did not have health insurance coverage of infertility. On average, patients spent around 18% of their annual income on infertility care, excluding major surgeries.

Conclusion: Male infertility is a worrisome medical condition that causes a huge burden on the Kuwait community. Effective management necessitates insurance coverage and public health support owing to the huge financial burden on the patients and their partners. Thus, policymakers should re-evaluate their protocols of spending on male infertility care.

Keywords: Cost; Kuwait; insurance; male infertility.

 

Conflict of interest statement

There are no conflicts of interest.

Similar articles

The Out-of-Pocket Cost Burden of Cancer Care-A Systematic Literature Review.

Iragorri N, de Oliveira C, Fitzgerald N, Essue B.Curr Oncol. 2021 Mar 15;28(2):1216-1248. doi: 10.3390/curroncol28020117.PMID: 33804288 Free PMC article. Review.

In vitro fertilization and multiple pregnancies: an evidence-based analysis.

Medical Advisory Secretariat.Ont Health Technol Assess Ser. 2006;6(18):1-63. Epub 2006 Oct 1.PMID: 23074488 Free PMC article.

Insurance coverage for male infertility care in the United States.

Dupree JM.Asian J Androl. 2016 May-Jun;18(3):339-41. doi: 10.4103/1008-682X.177838.PMID: 27030084 Free PMC article. Review.

Cost of Investigating Neurological Disease: Experience of a Tertiary Care Center in Karachi, Pakistan.

Faruqi SJ, Shahbaz NN, Nisa Q, Umer SR, Ali SG, Aziz MY.Cureus. 2020 Jul 20;12(7):e9291. doi: 10.7759/cureus.9291.PMID: 32832289 Free PMC article.

[Annual epidemiological and health insurance disease burden of pertrochanteric fractures in Hungary].

Gazsó T, Elmer D, Endrei D, Sebestyén A, Kajos LF, Wiegand N, Boncz I.Orv Hetil. 2021 Mar 28;162(162 Suppl 1):46-53. doi: 10.1556/650.2021.32162.PMID: 33774608 Hungarian.

 

KMEL References

https://pubmed.ncbi.nlm.nih.gov

References

  1.  
    1. Zegers-Hochschild F, Adamson GD, de Mouzon J, Ishihara O, Mansour R, Nygren K, et al. The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) Revised Glossary on ART Terminology, 2009. Hum Reprod. 2009;24:2683–7. - PubMed
  2.  
    1. Mohammed F, Al-Yatama F, Al-Bader M, Tayel SM, Gouda S, Naguib KK. Primary male infertility in Kuwait: A cytogenetic and molecular study of 289 infertile Kuwaiti patients. Andrologia. 2007;39:87–92. - PubMed
  3.  
    1. Cooper TG, Noonan E, von Eckardstein S, Auger J, Baker HW, Behre HM, et al. World Health Organization reference values for human semen characteristics. Hum Reprod Update. 2010;16:231–45. - PubMed
  4.  
    1. Matetakufa S. Our own gift. New Int. 1998:11–2.
  5.  
    1. Eisenberg ML, Lathi RB, Baker VL, Westphal LM, Milki AA, Nangia AK. Frequency of the male infertility evaluation: Data from the national survey of family growth. J Urol. 2013;189:1030–4. -PubMed
  6.  
    1. Mehta A, Nangia AK, Dupree JM, Smith JF. Limitations and barriers in access to care for male factor infertility. Fertil Steril. 2016;105:1128–37. - PubMed
  7.  
    1. Dupree JM. Insurance coverage for male infertility care in the United States. Asian J Androl. 2016;18:339–41. - PMC - PubMed
  8.  
    1. Smith JF, Eisenberg ML, Glidden D, Millstein SG, Cedars M, Walsh TJ, et al. Socioeconomic disparities in the use and success of fertility treatments: Analysis of data from a prospective cohort in the United States. Fertil Steril. 2011;96:95–101. - PMC - PubMed
  9.  
    1. Elliott P, Abad-Santos M, Katz P, Smith J. PD52-09 out of pocket costs of male infertility care and associated financial strain. J Urol. 2015;4:e1116.
  10.  
    1. Medicine PCotASfR. Diagnostic evaluation of the infertile female: A committee opinion. Fertil Steril. 2015;103:e44–50. - PubMed
  11.  
    1. Cayan S, Erdemir F, Ozbey I, Turek PJ, Kadioǧlu A, Tellaloǧlu S. Can varicocelectomy significantly change the way couples use assisted reproductive technologies? J Urol. 2002;167:1749–52. -PubMed
  12.  
    1. Dupree JM. Insurance coverage of male infertility: What should the standard be? Transl Androl Urol. 2018;7:S310–6. - PMC - PubMed
  13.  
    1. Kolettis PN, Sabanegh ES. Significant medical pathology discovered during a male infertility evaluation. J Urol. 2001;166:178–80. - PubMed
  14.  
    1. Walsh TJ, Croughan MS, Schembri M, Chan JM, Turek PJ. Increased risk of testicular germ cell cancer among infertile men. Arch Intern Med. 2009;169:351–6. - PMC - PubMed
  15.  
    1. Walsh TJ, Schembri M, Turek PJ, Chan JM, Carroll PR, Smith JF, et al. Increased risk of high-grade prostate cancer among infertile men. Cancer. 2010;116:2140–7. - PMC - PubMed
  16.  
    1. Eisenberg ML, Park Y, Hollenbeck AR, Lipshultz LI, Schatzkin A, Pletcher MJ. Fatherhood and the risk of cardiovascular mortality in the NIH-AARP Diet and Health Study. Hum Reprod. 2011;26:3479–85. - PMC - PubMed
  17.  
    1. Connolly MP, Hoorens S, Chambers GM ESHRE Reproduction and Society Task Force. The costs and consequences of assisted reproductive technology: An economic perspective. Hum Reprod Update. 2010;16:603–13. - PubMed
  18.  
    1. De Neubourg D, Bogaerts K, Wyns C, Albert A, Camus M, Candeur M, et al. The history of Belgian assisted reproduction technology cycle registration and control: A case study in reducing the incidence of multiple pregnancy. Hum Reprod. 2013;28:2709–19. - PubMed
  19.  
    1. Chambers GM, Sullivan EA, Ishihara O, Chapman MG, Adamson GD. The economic impact of assisted reproductive technology: A review of selected developed countries. Fertil Steril. 2009;91:2281–94. - PubMed

 

Page Navigation